scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJM198405033101801 |
P698 | PubMed publication ID | 6709008 |
P2093 | author name string | Thomas A | |
Davies MJ | |||
P433 | issue | 18 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | thrombosis | Q261327 |
P304 | page(s) | 1137-1140 | |
P577 | publication date | 1984-05-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death | |
P478 | volume | 310 |
Q36931265 | "Lone aspiration thrombectomy" without stenting in young patients with ST elevation myocardial infarction |
Q22241919 | 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines |
Q56374277 | A Survey on Coronary Atherosclerotic Plaque Tissue Characterization in Intravascular Optical Coherence Tomography |
Q68379172 | A critical approach to the study of new agents for the prevention of arterial thrombosis: a comment |
Q72230724 | A new clinical classification for hospital prognosis of unstable angina pectoris |
Q52326366 | A new system for classification of cardiac death as arrhythmic, ischemic, or due to myocardial pump failure. |
Q33612993 | A patient in whom self-terminating ventricular fibrillation was a manifestation of myocardial reperfusion |
Q38028220 | A potential role for integrin signaling in mechanoelectrical feedback |
Q48194474 | A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction |
Q34495491 | A rabbit model of thrombosis on atherosclerotic lesions |
Q41971261 | A rare case of double infarction treated with primary percutaneous coronary intervention |
Q34903466 | A short-term risk-benefit analysis of occasional and regular use of low-dose aspirin in primary prevention of vascular diseases: a nationwide population-based study |
Q62977574 | Activated human platelet products induce proarrhythmic effects in ventricular myocytes |
Q73364939 | Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors |
Q47782268 | Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment |
Q41582118 | Acute and chronic psychological risk factors for coronary syndromes: moderating effects of coronary artery disease severity |
Q41915537 | Acute coronary artery obstruction in myocardial infarction: overview of thrombolytic therapy |
Q35878289 | Acute coronary events |
Q70635893 | Acute myocardial infarction with normal coronary arteries |
Q26801144 | Adjunctive therapies to reduce thrombotic events in patients with a history of myocardial infarction: role of vorapaxar |
Q50632678 | An age-related difference in the ratio of sudden coronary death over acute myocardial infarction in Estonian males. |
Q53897107 | An ischemia-guided approach for risk stratification in patients with acute coronary syndromes. |
Q30752767 | Anatomy, histology, and pathology of coronary arteries: a review relevant to new interventional and imaging techniques--Part II |
Q38773302 | Anatomy, histology, and pathology of the major epicardial coronary arteries relevant to echocardiographic imaging techniques |
Q37718905 | Angiographic and Clinical Impact of Successful Manual Thrombus Aspiration in Diabetic Patients Undergoing Primary PCI. |
Q77295565 | Angiographic characteristics of infarct-related and non-infarct-related stenoses in patients in whom stable angina progressed to acute myocardial infarction |
Q70018285 | Angiographic evolution of coronary artery morphology in unstable angina |
Q78032654 | Angiographic plaque complexity: the tip of the unstable plaque iceberg |
Q53970366 | Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis. |
Q70061936 | Angioplasty for stable versus unstable angina pectoris: are unstable patients more likely to get restenosis? A quantitative angiographic study in 339 consecutive patients |
Q52480523 | Angioscopic Evaluation of Coronary-Artery Thrombi in Acute Coronary Syndromes |
Q73833366 | Angioscopic evaluation of angiographically complex coronary lesions |
Q34586858 | Animal models of spontaneous plaque rupture: the holy grail of experimental atherosclerosis research. |
Q44520548 | Anti-atherogenic effects of 3,4-Dihydroxy hydrocinnamides |
Q48113765 | Anti-inflammatory therapies in myocardial infarction: failures, hopes, and challenges |
Q34441606 | Anticoagulation and the heart |
Q33805244 | Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents |
Q33606832 | Antiplatelet therapy--Part I |
Q33822508 | Antiplatelet use in interventional cardiology |
Q44733408 | Apolipoprotein A and prognosis after myocardial infarction in non-diabetic men |
Q37458988 | Arrhythmia pharmacogenomics: methodological considerations. |
Q26774150 | Aspirin for primary prevention of cardiovascular disease |
Q39635710 | Aspirin in cardiovascular disease |
Q38667776 | Association between gaseous air pollutants and inflammatory, hemostatic and lipid markers in a cohort of midlife women. |
Q73175230 | Asynchronous left ventricular wall motion in unstable angina |
Q52533070 | Atherosclerosis and acute coronary events. |
Q36070404 | Atherosclerosis imaging: intravascular ultrasound |
Q42581726 | Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease |
Q48186465 | Atherosclerotic plaque at the carotid bifurcation: CT angiographic appearance with histopathologic correlation |
Q35027570 | B-mode ultrasound and spiral CT for the assessment of carotid atherosclerosis |
Q35219524 | Basic aspects of plaque vulnerability |
Q39468185 | Beta-blockers and calcium antagonists in angina pectoris. The potential role of combination therapy |
Q39612745 | Bimodal presentation of the clinical syndromes of coronary atherosclerosis: a review |
Q49332565 | Bioengineered in vitro models of thrombosis: methods and techniques |
Q33596823 | Biomarkers in acute myocardial infarction. |
Q42381472 | Bioprinted thrombosis-on-a-chip |
Q47688285 | Blood Hemostatic Changes During an Ultraendurance Road Cycling Event in a Hot Environment |
Q24615319 | Brain-heart interactions. The neurocardiology of arrhythmia and sudden cardiac death |
Q37808380 | CT Coronary Calcification: What Does a Score of “0” Mean? |
Q35141697 | Can the DNA damage response be harnessed to modulate atherosclerotic plaque phenotype? |
Q42979603 | Cardiac and whole body [3H]noradrenaline kinetics in ischaemic heart disease: contrast between unstable anginal syndromes and pacing induced ischaemia |
Q36362468 | Cardiac arrhythmias and sudden death in infancy: implication for the medicolegal investigation |
Q37467446 | Cardiac catheterization is underutilized after in-hospital cardiac arrest |
Q54080510 | Cardiopulmonary bypass and activation of antithrombotic plasma protein C. |
Q77745893 | Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT) |
Q71954715 | Carotid artery plaque composition--relationship to clinical presentation and ultrasound B-mode imaging. European Carotid Plaque Study Group |
Q37691726 | Carotid plaque neovascularization and hemorrhage detected by MR imaging are associated with recent cerebrovascular ischemic events |
Q40911999 | Carotid plaque typing by multiple-parameter ultrasonic tissue characterization |
Q34337699 | Carotid ultrasound. |
Q41580249 | Causes of sudden death in young and middle-aged competitive athletes |
Q52005397 | Changes in hemostatic function at times of cyclic variation in occupational stress. |
Q33671925 | Characterization of the unstable lesion by angiography, angioscopy, and intravascular ultrasound |
Q35633523 | Cholesterol and lipoproteins: beyond atherogenesis |
Q48457643 | Chronobiological patterns of onset of acute cerebrovascular diseases |
Q42577631 | Circulating endothelin in acute ischaemic syndromes |
Q92578824 | Clinical Factors Associated with Obstructive Coronary Artery Disease in Patients with Out-of-Hospital Cardiac Arrest: Data from the Korean Cardiac Arrest Research Consortium (KoCARC) Registry |
Q73199234 | Clinical and angiographic implications of coronary stenting in thrombus-containing lesions |
Q74562163 | Clinical and angiographic outcome of Micro Stent II implantation in native coronary arteries |
Q61669026 | Clinical experience with antithrombotic drugs acting on purine receptor pathways |
Q36482914 | Clinical perspective on celiprolol: Cardioprotective potential |
Q33840696 | Coagulation-induced resistance to fluid flow in small-diameter vascular grafts and graft mimics measured by purging pressure |
Q35778260 | Combined ECG, Echocardiographic, and Biomarker Criteria for Diagnosing Acute Myocardial Infarction in Out-of-Hospital Cardiac Arrest Patients |
Q34128128 | Combined two-photon luminescence microscopy and OCT for macrophage detection in the hypercholesterolemic rabbit aorta using plasmonic gold nanorose |
Q36791681 | Comparing percutaneous coronary intervention and thrombolysis in patients with return of spontaneous circulation after cardiac arrest |
Q30447937 | Comparison of Coronary Plaque Components between Non-Culprit Lesions in Patients with Acute Coronary Syndrome and Target Lesions in Patients with Stable Angina: Virtual Histology-Intravascular Ultrasound Analysis |
Q71906107 | Comparison of coronary angiographic narrowing in stable angina pectoris, unstable angina pectoris, and in acute myocardial infarction |
Q83907507 | Comparison of ruptured coronary plaques in patients with unstable and stable clinical presentation |
Q73713135 | Compensatory enlargement of the coronary artery in acute myocardial infarction |
Q37567965 | Complete Revascularization of Simultaneous Multiple Culprit Lesions in a Septuagenarian with ST-Elevation Myocardial Infarction. |
Q44823533 | Complicated atherosclerotic lesions: A potential cause of ischemic ventricular arrhythmias in cardiac arrest survivors who do not have inducible ventricular tachycardia? |
Q38737722 | Control of plasma fibrinogen levels |
Q57636187 | Conversion from chronic to acute coronary artery disease: Speculation regarding mechanisms |
Q47172105 | Coronary CT angiography features of ruptured and high-risk atherosclerotic plaques: Correlation with intra-vascular ultrasound |
Q40459835 | Coronary Plaque Disruption |
Q36760411 | Coronary anatomy in patients with various manifestations of three vessel coronary artery disease |
Q70421814 | Coronary angiographic and morphologic correlation |
Q54483847 | Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. |
Q73809234 | Coronary arterial remodeling in differing clinical presentations of unstable angina pectoris--an intravascular ultrasound study |
Q35062347 | Coronary arterial remodeling: from bench to bedside |
Q37005332 | Coronary artery diameter related to calcium scores and coronary risk factors as measured with multidetector computed tomography: a substudy of the ACCURACY trial |
Q45139540 | Coronary artery thrombosis and myocardial infarction |
Q58492235 | Coronary atherosclerosis in unheralded sudden coronary death under age 50: histo-pathologic comparison with ‘healthy’ subjects dying out of hospital |
Q96304404 | Coronary inflammation: why searching, how to identify and treat it |
Q33802871 | Coronary microembolization--its role in acute coronary syndromes and interventions |
Q44827749 | Coronary occlusion: cause or consequence of acute myocardial infarction? |
Q36837274 | Coronary revascularization treatment based on dual-source computed tomography. |
Q26830317 | Coronary thrombus in patients undergoing primary PCI for STEMI: Prognostic significance and management |
Q35037630 | Critical review of unstable angina and non-ST elevation myocardial infarction |
Q33687017 | Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle |
Q33759411 | Current status of radionuclide tracer imaging of thrombi and atheroma |
Q42376295 | Decreased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability |
Q60925002 | Deep arterial injury during experimental angioplasty: Relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis |
Q36418295 | Delineation of peripheral and coronary detail by intraoperative angioscopy |
Q39453641 | Design and methodology of the PURSUIT trial: evaluating eptifibatide for acute ischemic coronary syndromes. Platelet Glycoprotein IIb-IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy |
Q35151260 | Detection of high-risk atherosclerotic coronary plaques by intravascular spectroscopy |
Q42020555 | Determinants of disease and disability in the elderly: The Rotterdam elderly study |
Q34821621 | Devices for the management of ventricular arrhythmias in cardiac failure |
Q36301365 | Diabetic angiopathy and angiogenic defects |
Q51838349 | Diagnosis and management of out-of-hospital cardiac arrest secondary to coronary artery spasm. |
Q44610787 | Dietary fatty acids and blood coagulation |
Q44348310 | Different pathways for sodium entry in cardiac cells during ischemia and early reperfusion. |
Q40430420 | Direct Angioplasty In Acute Myocardial Infarction: State of the Art and Current Controversies |
Q36129679 | Direct Comparison of Virtual-Histology Intravascular Ultrasound and Optical Coherence Tomography Imaging for Identification of Thin-Cap Fibroatheroma |
Q92512604 | Do MCHC, MPV, and Procalcitonin Levels Determine Prognosis in Acute Coronary Syndrome? |
Q37352106 | Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis |
Q33901369 | Dual-wavelength multifrequency photothermal wave imaging combined with optical coherence tomography for macrophage and lipid detection in atherosclerotic plaques using gold nanoparticles |
Q37706744 | Early coronary revascularization improves 24h survival and neurological function after ischemic cardiac arrest. A randomized animal study |
Q36823429 | Early remodelling of coronary stenoses after thrombolytic treatment in patients with acute myocardial infarction |
Q74611564 | Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials |
Q35049195 | Effect of clopidogrel on the expression of inflammatory markers in rabbit ischemic coronary artery |
Q38803595 | Effect of low extracellular pH on NF-κB activation in macrophages |
Q74003566 | Effect of polyphenolic flavonoid compounds on platelets |
Q83932197 | Effects of emotional and physiological stress on plaque instability in apolipoprotein E knockout mice |
Q74015185 | Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study |
Q39758354 | Eicosanoid biosynthesis in human cardiovascular disease |
Q71974401 | Endogenous and Exogenous Nitric Oxide Protect Against Intracoronary Thrombosis and Reocclusion After Thrombolysis |
Q52881035 | Enhanced vasomotor responses of complex coronary stenoses to acetylcholine in stable angina pectoris. |
Q41047249 | Epidemiologic aspects of circadian patterns of cardiovascular disease and triggers of acute cardiac events. |
Q34000106 | Etiology of sudden death in the community: results of anatomical, metabolic, and genetic evaluation |
Q45879832 | Factor VIII and coronary heart disease |
Q40492595 | Fibrinogen in Human Atherosclerosis |
Q40582633 | Fibrinolysis and thrombosis |
Q72586948 | Fibrinopeptide A and sudden coronary death |
Q28222129 | Fighting against sudden death: a single or multidisciplinary approach |
Q39645241 | Future approaches to the treatment of hypertension in the light of results from recent trials |
Q33735581 | Future directions in thrombolysis. |
Q41930888 | Gene expression analysis: Regulation of key genes associated with mycophenolate mofetil treatment of symptomatic carotid artery stenosis |
Q33958296 | Going to the heart of the matter: do negative emotions cause coronary heart disease? |
Q46536229 | Grognostic significance of programmed ventricular stimulation in patients surviving complicated acute myocardial infarction: A prospective study |
Q36757211 | Haemostatic factors and ischaemic heart disease. The Caerphilly study |
Q69886150 | Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study |
Q33544360 | Has the survival of the heart failure population changed? Lessons from trials. |
Q35960796 | Heart disease is common in humans and chimpanzees, but is caused by different pathological processes |
Q41047291 | Hemostatic factors as triggers of cardiovascular events. |
Q73560122 | Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction |
Q33671907 | Histopathology of plaque rupture |
Q42015763 | How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death? |
Q42186702 | Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin |
Q36832190 | Identification of Patients at Risk for Sudden Death in Congestive Heart Failure |
Q37447123 | In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography |
Q28167456 | Increased platelet CD63 and P-selectin expression persist in atherosclerotic ischemic stroke |
Q34125013 | Increased platelet deposition on atherosclerotic coronary arteries |
Q37370224 | Inflammation and plaque vulnerability |
Q44431760 | Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm. |
Q41593791 | Insights into the pathophysiology of unstable coronary artery disease |
Q30439779 | Integrated IVUS-OCT Imaging for Atherosclerotic Plaque Characterization |
Q39579033 | Interaction of lipoproteins with the artery wall |
Q67678146 | Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endothelium |
Q72034087 | Interstitial Collagenase (MMP-1) Expression in Human Carotid Atherosclerosis |
Q39624500 | Intraluminal thrombosis of coronary arteries in fatal myocardial infarctions and in failed aortocoronary saphenous vein grafts |
Q37832127 | Intravascular imaging of vulnerable coronary plaque: current and future concepts. |
Q30448691 | Intravascular photoacoustic imaging at 35 and 80 MHz |
Q38543810 | Intravascular ultrasound and optical coherence tomography imaging of coronary atherosclerosis |
Q35374491 | Is preinfarction angina related to the presence or absence of coronary plaque rupture? |
Q40485987 | Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies |
Q40440599 | Job stress and cardiovascular risk factors in male workers |
Q33999390 | Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis |
Q42057167 | Limitations of the exercise test as a screen for acute cardiac events in asymptomatic patients |
Q38464811 | Lipoprotein analyses in patients with stable angina and acute coronary syndrome |
Q88287339 | Long-term prognostic implication of coronary plaque characterization as detected by 64-multidetector computed tomography in Egyptian population |
Q41489551 | Loss of SPRR3 in ApoE-/- mice leads to atheroma vulnerability through Akt dependent and independent effects in VSMCs. |
Q39754948 | Louis F. Bishop lecture. Role of coronary artery spasm in symptomatic and silent myocardial ischemia |
Q33873624 | MRI discriminates thrombus composition and ST resolution after percutaneous coronary intervention in patients with ST-elevation myocardial infarction |
Q38008842 | Macrophage differentiation and function in atherosclerosis: opportunities for therapeutic intervention? |
Q52925691 | Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with Gadofluorine M. |
Q30305538 | Management of Acute Ischemic Coronary Syndromes: The Present and Future |
Q40933179 | Management of acute myocardial infarction: evaluating the past, practicing in the present, elaborating the future |
Q40466250 | Management of vasospastic angina?Role of nicorandil |
Q35088065 | Mechanisms of plaque vulnerability and rupture |
Q88000311 | Mechanisms of sudden cardiac death |
Q41472913 | Megakaryocytes and platelets in vascular disease |
Q38543354 | MicroRNAs in platelet function and cardiovascular disease |
Q72386574 | Minimal residual coronary obstructions in patients who suffered a first myocardial infarction. A prospective study comparing coronary angiography and exercise thallium scintigraphy |
Q42246588 | Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor. |
Q43085088 | Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure. |
Q74774981 | Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound |
Q33999181 | Morphological characteristics of clinically significant coronary artery stenosis in stable angina |
Q52548227 | Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. |
Q30436527 | Multiple culprit arteries in patients with ST segment elevation myocardial infarction referred for primary percutaneous coronary intervention |
Q52002827 | Multiple plaque morphologies in a single coronary artery: insights from volumetric intravascular ultrasound. |
Q73437961 | Multiple versus single coronary plaque ruptures detected by intravascular ultrasound in stable and unstable angina pectoris and in acute myocardial infarction |
Q35541075 | Myeloperoxidase modulation by LDL apheresis in familial hypercholesterolemia |
Q79366429 | Myocardial infarction associated with thrombus formation in non-culprit coronary arteries |
Q74079066 | Myocardial infarction in a 35-year-old man with homocysteinemia, high plasminogen activator inhibitor activity, and resistance to activated protein C |
Q28193160 | New anticoagulants in ischemic heart disease |
Q38665555 | New concepts in the pathophysiology of acute myocardial infarction |
Q41531482 | New insights into the pathogenesis and prevention of acute coronary syndromes |
Q35181680 | Nitric oxide and its relationship to thrombotic disorders |
Q37369997 | Nitric oxide released from activated platelets inhibits platelet recruitment |
Q90468299 | Non-atherosclerotic causes of acute coronary syndromes |
Q33150779 | Non-atherosclerotic coronary artery disease and sudden death in the young |
Q46535642 | Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography |
Q73295821 | Novel Antithrombotic Strategies for the Treatment of Coronary Artery Thrombosis: A Critical Appraisal |
Q37291810 | Obstructive sleep apnoea increases the incidence of morning peak of onset in acute myocardial infarction |
Q41762474 | Optical Coherence Tomography and Fibrous Cap Characterization |
Q44669232 | Optical coherence tomography guided in-stent thrombus removal in patients with acute coronary syndromes |
Q88048955 | Out-of-hospital cardiac arrest: current concepts |
Q49169467 | Out-of-hospital ventricular fibrillation in patients with acute myocardial infarction: coronary angiographic determinants |
Q37734973 | Outcome of out-of-hospital cardiac arrest after fibrinolysis with reteplase in comparison to the return of spontaneous circulation after cardiac arrest score in a geographic region without emergency coronary intervention |
Q38218902 | PET imaging of inflammation in atherosclerosis |
Q73364942 | Pathobiology of Myocardial Necrosis |
Q28195433 | Pathobiology, not angiography, should guide management in acute coronary syndrome/non-ST-segment elevation myocardial infarction: the non-interventionist's perspective |
Q33740239 | Pathogenesis and pathology of coronary heart disease syndromes |
Q70828602 | Pathogenesis of sudden ischaemic cardiac death |
Q33723960 | Pathogenic mechanisms in unstable angina |
Q77336402 | Pathological features of witnessed out-of-hospital cardiac arrest presenting with ventricular fibrillation |
Q64938119 | Pathology of Endovascular Stents. |
Q26738566 | Pathology of coronary atherosclerosis and thrombosis |
Q56945632 | Pathology of unstable angina: Analysis of biopsies obtained by directional coronary atherectomy |
Q41047270 | Pathophysiology and inflammatory aspects of plaque rupture |
Q36662537 | Pathophysiology of Sudden Cardiac Death |
Q70806202 | Pathophysiology of atherosclerotic heart disease |
Q71129084 | Pathophysiology of coronary artery disease |
Q38401393 | Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis |
Q35585929 | Pathophysiology of plaque rupture and the concept of plaque stabilization |
Q41386371 | Pathophysiology of plaque rupture and the concept of plaque stabilization |
Q70150299 | Pathophysiology of unstable angina |
Q70483884 | Paunches and the prediction of coronary heart disease |
Q39003245 | Peroxisome Proliferator-Activated Receptor γ Induces the Expression of Tissue Factor Pathway Inhibitor-1 (TFPI-1) in Human Macrophages. |
Q34021587 | Pharmacological management of acute myocardial infarction |
Q33899039 | Pioneer research in Britain into atherosclerosis and coronary heart disease--an historical review |
Q47144705 | Plaque Rupture in Coronary Atherosclerosis Is Associated With Increased Plaque Structural Stress |
Q33671913 | Plaque disruption and thrombosis. Potential role of inflammation and infection |
Q74006762 | Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo |
Q39817564 | Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina |
Q78569983 | Plaque rupture and consequent thromboses probably do not cause acute coronary syndromes |
Q33832519 | Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity |
Q44560233 | Plasma triglyceride-rich lipoprotein remnants as a risk factor of 'Pokkuri disease'. |
Q34217461 | Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions |
Q33704606 | Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics |
Q73218236 | Platelet activation with exercise and risk of cardiac events |
Q41904796 | Platelet adhesion to collagen. Factors affecting Mg2(+)-dependent and bivalent-cation-independent adhesion |
Q24683880 | Platelet aggregation and incident ischaemic heart disease in the Caerphilly cohort |
Q44518777 | Platelet characteristics associated with coronary artery disease |
Q73815965 | Platelet glycoprotein Ia gene dimorphism alpha2-807 in malignant arrhythmia in coronary artery disease |
Q42150889 | Platelet transport rates and binding kinetics at high shear over a thrombus |
Q41968923 | Platelet-reactive sites in collagen. Collagens I and III possess different aggregatory sites |
Q68125873 | Platelets and antiplatelet therapy in ischemic heart disease |
Q37855541 | Platelets and cardiac arrhythmia |
Q37050963 | Positron emission tomography imaging of coronary atherosclerosis |
Q34239995 | Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings |
Q51565723 | Postprandial lipaemia and haemostatic factors. |
Q36433688 | Potential role of rivaroxaban in patients with acute coronary syndrome |
Q71906135 | Predictive value of hemostatic factors for sudden death in patients with stable angina pectoris |
Q88195610 | Preventive Percutaneous Coronary Intervention in ST-elevation Myocardial Infarction - The Primacy of Randomised Trials |
Q39467756 | Primary prevention of vascular disease by aspirin |
Q52714979 | Prognostic value of blood count parameters in patients with acute coronary syndrome. |
Q37192668 | Prognostic value of low and moderately elevated C-reactive protein in acute coronary syndrome: a 2-year follow-up study |
Q50891002 | Progressive intermittent claudication is associated with impaired fibrinolysis. |
Q36682178 | Prostaglandins and the cardiovascular system: a review and update |
Q103758146 | RNA-seq identifies circulating miRNAs as potential biomarkers for plaque rupture in patients with ST-segment elevation myocardial infarction |
Q41612083 | Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo |
Q36383706 | Reducing the risks of sudden death and heart failure post myocardial infarction: utility of optimized pharmacotherapy |
Q30469057 | Relation between anemia and vulnerable coronary plaque components in patients with acute coronary syndrome: virtual histology-intravascular ultrasound analysis |
Q35214585 | Relation between high-sensitivity C-reactive protein and coronary plaque components in patients with acute coronary syndrome: virtual histology-intravascular ultrasound analysis |
Q40972097 | Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia II |
Q36306289 | Relation of Angiographic Thrombus Burden with Severity of Coronary Artery Disease in Patients with ST Segment Elevation Myocardial Infarction |
Q37175334 | Relationship between retinal vascular caliber and coronary artery disease in patients with non-alcoholic fatty liver disease (NAFLD) |
Q44549574 | Residual flow to the infarct zone against lethal ventricular tachyarrhythmias during the acute phase of myocardial infarction. |
Q41593826 | Revascularization of patients with unstable coronary artery disease: the case for early intervention. |
Q92632814 | Review of the state of the art in cardiovascular endoscopy imaging of atherosclerosis using photoacoustic techniques with pulsed and continuous-wave optical excitations |
Q72772577 | Risk stratification after myocardial infarction: role of electrical instability, ischemia, and left ventricular function |
Q34247699 | Risk stratification in patients with chest pain |
Q37421039 | Risk-benefit assessment of antiarrhythmic drugs. An epidemiological perspective |
Q26799324 | Role of Intravascular Ultrasound in Patients with Acute Myocardial Infarction |
Q37683958 | Role of acute infection in triggering acute coronary syndromes. |
Q39749143 | Role of antithrombotic therapy in unstable angina, myocardial infarction and sudden death |
Q38715461 | Role of biomechanical forces in the natural history of coronary atherosclerosis. |
Q37656351 | Role of coronary angiography for out-of-hospital cardiac arrest survivors according to postreturn of spontaneous circulation on an electrocardiogram |
Q41593796 | Role of inflammation in the pathogenesis of unstable coronary artery disease. |
Q51741512 | Role of mean platelet volume in triagging acute coronary syndromes. |
Q34084212 | Role of plaque rupture in acute coronary syndromes |
Q39820647 | Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death |
Q93604988 | Role of the vascular endothelial cell antigen system in the etiology of atherosclerosis |
Q35833262 | Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. |
Q33546230 | Secondary prevention of myocardial infarction: role of beta-adrenergic blockers and angiotensin-converting enzyme inhibitors |
Q57189831 | Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo |
Q43077504 | Serum levels of gelatinase associated lipocalin as indicator of the inflammatory status in coronary artery disease |
Q43473309 | Serum myeloperoxidase level predicts reperfusion in patients with myocardial infarction receiving thrombolytic therapy |
Q37732247 | Shear stress and plaque development |
Q73265850 | Short- and long-term risk factors for sudden death in patients with stable angina |
Q92164140 | Sighting acute myocardial infarction through platelet gene expression |
Q41890857 | Simultaneous double coronary thrombosis in a 47-year-old male patient with acute myocardial infarction |
Q48087734 | Six-year survival of patients with and without painless myocardial ischemia and out-of-hospital ventricular fibrillation |
Q35376940 | Size of emptied plaque cavity following spontaneous rupture is related to coronary dimensions, not to the degree of lumen narrowing. A study with intravascular ultrasound in vivo |
Q41810578 | Spontaneous and interventional coronary microembolisation |
Q33762073 | Stable versus unstable atherosclerosis: clinical aspects |
Q51766324 | Stenosis and vascular damage as a cause of thrombosis in the dog femoral artery. |
Q36832188 | Sudden Death in Congestive Heart Failure |
Q71711873 | Sudden cardiac death |
Q77385212 | Sudden cardiac death |
Q78164493 | Sudden cardiac death |
Q57649054 | Sudden cardiac death |
Q36660378 | Sudden cardiac death after myocardial infarction |
Q39845633 | Sudden cardiac death and acute coronary thrombosis |
Q36684008 | Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs |
Q35767296 | Sudden cardiac death in patients with diabetes |
Q33175656 | Sudden cardiac death in the athlete |
Q40877795 | Sudden cardiac death. Magnitude of the problem, substrate/trigger interaction, and populations at high risk. |
Q51153261 | Sudden cardiac death: An 11-year postmortem analysis in the region of Epirus, Greece |
Q34118092 | Sudden coronary death in Glasgow: nature and frequency of acute coronary lesions. |
Q34118171 | Sudden coronary death in Glasgow: the severity and distribution of chronic coronary atherosclerotic stenoses. |
Q70696114 | Sudden coronary death: comparison of patients with to those without coronary thrombus at necropsy |
Q34036851 | Sudden death and vigorous exercise--a study of 60 deaths associated with squash |
Q61716906 | Sudden death in heart failure: vascular or electrical? |
Q39820634 | Sudden death: lessons from subsets in population studies |
Q35583087 | Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study |
Q52318611 | Summation and Cancellation Effects on QRS and ST-Segment Changes Induced by Simultaneous Regional Myocardial Ischemia. |
Q30307449 | Tachyarrhythmias associated with acute myocardial infarction |
Q36090166 | Targeting the vulnerable plaque: the evolving role of nuclear imaging |
Q33970630 | Techniques characterizing the coronary atherosclerotic plaque: influence on clinical decision making? |
Q38985960 | Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease |
Q40488917 | Terrein: a new melanogenesis inhibitor and its mechanism. |
Q38215200 | The Jeremiah Metzger lecture. Participation of eicosanoids in the syndromes of myocardial ischemia |
Q83200066 | The Renin-Angiotensin and fibrinolytic systems co-conspirators in the pathogenesis of ischemic cardiovascular disease |
Q50320740 | The Severity of Coronary Arterial Stenosis in Patients With Acute ST-Elevated Myocardial Infarction: A Thrombolytic Therapy Study. |
Q42564547 | The aetiology of myocardial injury after non-cardiac surgery |
Q39612957 | The combination of antianginal drugs: effects and indications |
Q41964030 | The complex fate in plasma of gadolinium incorporated into high-density lipoproteins used for magnetic imaging of atherosclerotic plaques |
Q35818946 | The coronary arteries in cases of cardiac and noncardiac sudden death |
Q34557199 | The epidemiology of out-of-hospital 'sudden' cardiac arrest |
Q37947959 | The management of thrombotic lesions in the cardiac catheterization laboratory |
Q35134598 | The menopause and HRT. Hormone replacement therapy, cardiovascular and cerebrovascular disease. |
Q26830602 | The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment |
Q29547827 | The pathogenesis of atherosclerosis: a perspective for the 1990s |
Q41727512 | The role of blood platelets in coronary atherosclerosis and thrombosis |
Q33809060 | The role of coronary angioplasty and stenting in acute myocardial infarction |
Q39764672 | The role of coronary artery lesions in ischemic heart disease: insights from recent clinicopathologic, coronary arteriographic, and experimental studies |
Q36239515 | The role of shear stress in the generation of rupture-prone vulnerable plaques |
Q77100958 | The significance of coronary arterial patency and ventricular function for prognosis after myocardial infarction |
Q37057557 | The spectrum of epidemiology underlying sudden cardiac death |
Q36480698 | Thematic review series: patient-oriented research. Imaging atherosclerosis: state of the art. |
Q38131399 | Therapeutic effects of Shenfu Injection on post-cardiac arrest syndrome |
Q44868404 | Thrombin-Responsive Transcutaneous Patch for Auto-Anticoagulant Regulation |
Q38614221 | Thrombolysis in the management of acute myocardial infarction and unstable angina pectoris |
Q41309558 | Thrombosis and ischaemic heart disease |
Q42648737 | Thrombus Aspiration during Percutaneous coronary intervention in Acute non-ST-elevation myocardial infarction Study (TAPAS II)-Study design |
Q33838184 | Tissue factor in human coronary atherosclerotic plaques |
Q73164621 | Tissue-factor antigen and activity in human coronary atherosclerotic plaques |
Q35709923 | Training for coronary angioplasty |
Q33579199 | Treating myocardial infarction in the post-GUSTO era. A European perspective |
Q37078895 | Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death |
Q71877815 | Ulcerated atherosclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: A multiplane transesophageal echocardiographic study |
Q24800403 | Ultrasound imaging versus morphopathology in cardiovascular diseases. Coronary collateral circulation and atherosclerotic plaque |
Q35622041 | Unheralded sudden cardiac death: do autonomic tone and thrombosis interact as key factors in aetiology? |
Q28192025 | Unstable angina and non-ST-segment elevation myocardial infarction: perspectives on combination therapy |
Q34733130 | Unstable angina: 1985 update. |
Q40925433 | Unstable angina: new insights into pathophysiologic characteristics, prognosis, and management strategies |
Q39665911 | Use of nitrates in the treatment of unstable and variant angina. |
Q52515747 | Vascular events responsible for thrombotic occlusion of a blood vessel. |
Q93053742 | Vascular smooth muscle cells in atherosclerosis |
Q33175295 | Vasospasm in smooth coronary arteries as a cause of asystole and syncope |
Q33545475 | Ventricular arrhythmias, electrophysiologic studies, and devices |
Q73725429 | Ventricular arrhythmias, electrophysiologic studies, and devices |
Q38557640 | Walking to health |
Q72111591 | When Is Bypass Surgery Enough? The Answer Is Still Uncertain |
Q48973377 | Who's afraid of angina pectoris? Separating the symptom from the marker |
Q37456404 | Witnessing ischemia or proofing coronary atherosclerosis: two different windows on the same or on different pathways precipitating cardiovascular events? |
Q85659772 | [Coronary atherosclerosis and progression to unstable plaques : Histomorphological and molecular aspects] |
Q80106732 | [Inflammation in acute coronary syndromes: mechanisms and clinical implications] |
Q73660409 | [Ischemic sudden death: critical analysis of risk markers. Part VIII] |
Q73353360 | [Prognostic value of the determination of C-reactive protein in unstable angina] |
Q74601172 | [Sudden death caused by atheromatous coronary disease in the young] |
Q36526300 | α-Linolenic Acid: Functions and Effects on Linoleic Acid Metabolism and Eicosanoid-Mediated Reactions |
Q36714040 | γ-Glutamyltransferase and Risk of Sudden Cardiac Death in Middle-Aged Finnish Men: A New Prospective Cohort Study |
Search more.